id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-0002-0026,FDA,FDA-2020-N-0002,FOI Summary cN 141 526 approved January 11 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T17:55:16Z,,0,0,0900006484a9ec38
FDA-2020-N-0002-0045,FDA,FDA-2020-N-0002,FOI Summary sA 200-466 approved February 8 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:05:48Z,,0,0,0900006484aa0127
FDA-2020-N-0002-0032,FDA,FDA-2020-N-0002,FOI Summary oA 200-675 approved January 12 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:00:19Z,,0,0,0900006484a9ecca
FDA-2020-N-0002-0044,FDA,FDA-2020-N-0002,FOI Summary oN 141-540 Approved February 26 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:05:17Z,,0,0,0900006484aa0118
FDA-2020-N-0002-0028,FDA,FDA-2020-N-0002,FOI Summary cN 200 506 approved February 16 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T17:58:13Z,,0,0,0900006484a9ec3b
FDA-2020-N-0002-0033,FDA,FDA-2020-N-0002,FOI Summary oA 200-676 approved January 12 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:00:49Z,,0,0,0900006484a9ecd3
FDA-2020-N-0002-0041,FDA,FDA-2020-N-0002,FOI Summary oN 141-530 approved March 15 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:04:03Z,,0,0,0900006484a9f1cc
FDA-2020-N-0002-0037,FDA,FDA-2020-N-0002,FOI Summary oA 200-684 approved February 1 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:02:32Z,,0,0,0900006484a9f1b2
FDA-2020-N-0002-0036,FDA,FDA-2020-N-0002,FOI Summary oA 200-683 approved February 1 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:02:02Z,,0,0,0900006484a9f163
FDA-2020-N-0002-0046,FDA,FDA-2020-N-0002,FOI Summary sN 132-872 approved March 24 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:06:12Z,,0,0,0900006484aa0130
FDA-2020-N-0002-0027,FDA,FDA-2020-N-0002,FOI Summary cN 141 544 approved January 14 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T17:55:59Z,,0,0,0900006484a9ec3a
FDA-2020-N-0002-0029,FDA,FDA-2020-N-0002,FOI Summary oA 200-625 approved March 22 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T17:58:36Z,,0,0,0900006484a9f064
FDA-2020-N-0002-0035,FDA,FDA-2020-N-0002,FOI Summary oA 200-678 approved January 12 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:01:40Z,,0,0,0900006484a9f15c
FDA-2020-N-0002-0042,FDA,FDA-2020-N-0002,FOI Summary oN 141-531 approved March 19 2021  re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:04:35Z,,0,0,0900006484a9fee0
FDA-2020-N-0002-0047,FDA,FDA-2020-N-0002,FOI Summary sN 141-336 approved January 7 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:06:28Z,,0,0,0900006484aa013b
FDA-2020-N-0002-0034,FDA,FDA-2020-N-0002,FOI Summary oA 200-677 approved January 12 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:01:21Z,,0,0,0900006484a9ece6
FDA-2020-N-0002-0039,FDA,FDA-2020-N-0002,FOI Summary oA 200-686 approved February 1 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:03:18Z,,0,0,0900006484a9f1bb
FDA-2020-N-0002-0043,FDA,FDA-2020-N-0002,FOI Summary oN 141-539 approved January 15 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:04:55Z,,0,0,0900006484a9fee1
FDA-2020-N-0002-0030,FDA,FDA-2020-N-0002,FOI Summary oA 200-657 approved February 18 2021re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T17:59:13Z,,0,0,0900006484a9f069
FDA-2020-N-0002-0040,FDA,FDA-2020-N-0002,FOI Summary oA 200-699 approved March 11 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:03:41Z,,0,0,0900006484a9f1c7
FDA-2020-N-0002-0031,FDA,FDA-2020-N-0002,FOI Summary oA 200-666 approved February 18 2021re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T17:59:51Z,,0,0,0900006484a9ecc8
FDA-2020-N-0002-0038,FDA,FDA-2020-N-0002,FOI Summary oA 200-685 approved February 1 2021 re New Animal Drugs; Approval of New Animal Drug Applications,Supporting & Related Material,Background Material,2021-04-08T04:00:00Z,2021,4,,,2021-04-08T18:02:55Z,,0,0,0900006484a9f1b5
FDA-2020-N-0002-0025,FDA,FDA-2020-N-0002,New Animal Drugs; Approval of New Animal Drug Applications,Rule,Final Rule,2021-04-01T04:00:00Z,2021,4,2021-04-01T04:00:00Z,,2021-04-01T16:02:40Z,2021-06704,0,0,0900006484a930d8
FDA-2020-N-0002-0024,FDA,FDA-2020-N-0002,"New Animal Drugs; Approval of New 
Animal Drug Applications; Changes of 
Sponsorship; Change of Sponsor’s 
Name and Address",Rule,Final Rule,2021-03-19T04:00:00Z,2021,3,2021-03-19T04:00:00Z,,2021-03-19T12:43:17Z,2021-05203,0,0,0900006484a71970
FDA-2020-N-0002-0022,FDA,FDA-2020-N-0002,FOI Summary oN 141 534 approved June 15 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:18:18Z,,0,0,0900006484a627a0
FDA-2020-N-0002-0014,FDA,FDA-2020-N-0002,FOI Summary oA 200 673 approved April 22 2020:New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:13:22Z,,0,0,0900006484a62c00
FDA-2020-N-0002-0013,FDA,FDA-2020-N-0002,FOI Summary oN 141-533 approved April 102020: New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:13:05Z,,0,0,0900006484a62bfb
FDA-2020-N-0002-0020,FDA,FDA-2020-N-0002,FOI Summary oA 200 682 approved June 2 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:16:27Z,,0,0,0900006484a6277b
FDA-2020-N-0002-0021,FDA,FDA-2020-N-0002,FOI Summary oA 200 399 approved June 4 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:16:50Z,,0,0,0900006484a6277c
FDA-2020-N-0002-0018,FDA,FDA-2020-N-0002,FOI Summary oA 200 638 approved May 27 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:15:46Z,,0,0,0900006484a62778
FDA-2020-N-0002-0011,FDA,FDA-2020-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Rule,Final Rule,2021-03-08T05:00:00Z,2021,3,2021-03-08T05:00:00Z,,2021-03-08T13:45:25Z,2021-04453,0,0,0900006484a629fd
FDA-2020-N-0002-0016,FDA,FDA-2020-N-0002,FOI Summary oA 200 679 approved May 14 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:14:07Z,,0,0,0900006484a62743
FDA-2020-N-0002-0012,FDA,FDA-2020-N-0002,FOI Summary cN 141 527 approved April 2 2020: New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:12:43Z,,0,0,0900006484a62616
FDA-2020-N-0002-0015,FDA,FDA-2020-N-0002,FOI Summary oA 200 674 approved April 27 2020  Copy; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:13:46Z,,0,0,0900006484a62c3d
FDA-2020-N-0002-0019,FDA,FDA-2020-N-0002,FOI Summary oA 200 134 approved June 1 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:16:07Z,,0,0,0900006484a62779
FDA-2020-N-0002-0023,FDA,FDA-2020-N-0002,FOI Summary oN 141 535 approved June 18 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:18:38Z,,0,0,0900006484a627a3
FDA-2020-N-0002-0017,FDA,FDA-2020-N-0002,FOI Summary oA 200 680 approved May 21 2020; New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Supporting & Related Material,Background Material,2021-03-08T05:00:00Z,2021,3,,,2021-03-08T21:14:29Z,,0,0,0900006484a62774
FDA-2020-N-0002-0008,FDA,FDA-2020-N-0002,"FOI Summary sN 141-322, approved March 27, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:51Z,,0,0,09000064847ae99e
FDA-2020-N-0002-0001,FDA,FDA-2020-N-0002,New Animal Drugs; Withdrawal of Approval of Abbreviated New Animal Drug Application,Rule,Withdrawal,2020-07-28T04:00:00Z,2020,7,2020-07-28T04:00:00Z,,2020-07-28T12:37:12Z,2020-15761,0,0,09000064847ae66a
FDA-2020-N-0002-0005,FDA,FDA-2020-N-0002,"FOI Summary oN 141-521, approved February 27, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:26Z,,0,0,09000064847ae99b
FDA-2020-N-0002-0007,FDA,FDA-2020-N-0002,"FOI Summary oA 200-586, approved March 23, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:43Z,,0,0,09000064847ae99d
FDA-2020-N-0002-0002,FDA,FDA-2020-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor,Rule,Final Rule,2020-07-28T04:00:00Z,2020,7,2020-07-28T04:00:00Z,,2020-07-28T12:42:56Z,2020-15760,0,0,09000064847ae6af
FDA-2020-N-0002-0006,FDA,FDA-2020-N-0002,"FOI Summary oA 200-670, approved March 10, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:34Z,,0,0,09000064847ae99c
FDA-2020-N-0002-0009,FDA,FDA-2020-N-0002,"EA sN 141-322, approved March 27, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:59Z,,0,0,09000064847ae99f
FDA-2020-N-0002-0003,FDA,FDA-2020-N-0002,"FOI Summary sN 141-466, approved January 28, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:09Z,,0,0,09000064847ae999
FDA-2020-N-0002-0010,FDA,FDA-2020-N-0002,"FONSI sN 141-322, approved March 27, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:03:07Z,,0,0,09000064847ae9a0
FDA-2020-N-0002-0004,FDA,FDA-2020-N-0002,"FOI Summary oA 200-614, approved February 7, 2020 re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor",Supporting & Related Material,Background Material,2020-07-28T04:00:00Z,2020,7,,,2020-07-28T13:02:17Z,,0,0,09000064847ae99a